Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03956654
Title A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)
Acronym RibOB
Recruitment Active, not recruiting
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Universitaire Ziekenhuizen Leuven
Age Groups: senior
Covered Countries BEL

No variant requirements are available.